Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04573530 · ClinicalTrials.gov registry record · NA

We Walk Plus Study for Older Adults With Intellectual Disabilities

A NA study of Intellectual Disability, sponsored by University of Illinois at Chicago.

Active
Registry status
NA
Development phase
46
Enrollment target
2
Study locations

NCT04573530 is a NA study of Intellectual Disability that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 46 participants, below the 352-participant average among 26 other Intellectual Disability trials with a reported enrollment target (87% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04573530, a NA study of Intellectual Disability, is active but no longer recruiting, sponsored by University of Illinois at Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
46 participants
Enrollment target
2
Study locations

Study Summary

Determine the feasibility and acceptability of We Walk Plus intervention to promote physical activity and improve cognition for older adults with intellectual disabilities (ID).

Conditions Studied

Interventions

  • BEHAVIORAL We Walk Plus Intervention

Study Locations (2)

Illinois

  • University of Illinois at Chicago - Chicago
  • Trinity Services Inc. - New Lenox

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2021-06-15
Est. Completion 2026-02-15
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT04573530

The ClinicalTrials.gov registry entry for NCT04573530 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 352-participant average among 26 other Intellectual Disability trials with a reported enrollment target (87% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intellectual Disability appearing as the primary indexed condition, and to 1 intervention - of which We Walk Plus Intervention is the first listed.

NCT04573530 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04573530 about?

NCT04573530 is a clinical study titled "We Walk Plus Study for Older Adults With Intellectual Disabilities". Determine the feasibility and acceptability of We Walk Plus intervention to promote physical activity and improve cognition for older adults with intellectual disabilities (ID).

What is the current status of trial NCT04573530?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2021-06-15. Estimated completion is 2026-02-15.

What conditions does trial NCT04573530 study?

This clinical trial studies the following conditions: Intellectual Disability.

What interventions are being tested in trial NCT04573530?

The interventions under investigation include: We Walk Plus Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04573530?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04573530 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intellectual Disability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.